Dallas Matthew D 4
4 · Biostage, Inc. · Filed Jun 5, 2019
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
Dallas Matthew D
Director
Transactions
- Award
Stock Option (right to buy)
2019-06-03+10,364→ 10,364 totalExercise: $2.90Exp: 2029-06-03→ Common Stock, par value $0.01 per share (10,364 underlying) - Award
Stock Option (right to buy)
2019-06-03+8,411→ 18,775 totalExercise: $2.90Exp: 2029-06-03→ Common Stock, par value $0.01 per share (8,411 underlying)
Footnotes (2)
- [F1]This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 3, 2019, December 3, 2019, March 3, 2020, and June 3, 2020.
- [F2]This Stock Option was granted in lieu of 2019 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2019, September 30, 2019, and December 31, 2019.